report cover1

Desmoid Tumors Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Demoid tumors are mesenchymal neoplasms that are considered locally invasive but non-metastasizing. They are also known as aggressive fibromatosis, deep fibromatosis, deep fibromatosis, and musculoaponeurotic fibromatosis. Even though they do not metastasize, they are locally invasive and cause significant morbidity and mortality. Desmoid tumor is primarily treated with surgery with or without radiation therapy. Despite surgical resection, DTs have a high rate of local recurrence, and hence they have been labeled as intermediate locally aggressive tumors by the World Health Organization. According to the World Health Organization, desmoid tumor is clonal fibroblastic proliferation that arises in the deep soft tissues and is characterized by infiltrative growth and a tendency toward local recurrence but an inability to metastasize even though it may be multifocal in the same limb or body part.

The etiology of DT is unknown. Most desmoid tumor occurs sporadically, and 85% have a mutation in the CTNNB1 encoding beta-catenin pathway. The three distinct mutations identified 41A, 45F, and 45. Mutation 45F is associated with a high risk of recurrence. The desmoid tumor is seen at increased frequency in familial adenomatous polyposis, mostly abdominal FAP caused by a mutation in the surgery in the APC gene. Desmoid tumor arising in FAP has a predilection for the prior surgical site, and previous surgery is a risk factor.

Global Desmoid Tumors Market – Competitive Landscape

On February 16, 2021, Iterion Therapeutics secured USD 17 million to advance the development of Tegavivint in multiple tumor settings. Companies investing continuously in the desmoid tumor market.

Some of the Key Players in the Global Desmoid Tumors Market Include –

  • SpringWorks
  • Ayala Therapeutics
  • Iterion Therapeutics
  • Pfizer
  • Novartis
  • Johnson & Johnson
  • Ayala Pharmaceutical
  • Abbott Laboratories
  • Bayer AG
  • Amgen Inc

Global Desmoid Tumors Market – Growth Drivers

Continued advancements in diagnostics technologies contribute to the early and accurate detection of desmoid tumors, facilitating prompt intervention and treatment, and thereby driving market growth. According to the National Center for Biotechnology Information (NCBI), the global incidence of desmoid tumors is approximately 3-5 cases per million person-years. Significant investments in research and development activities by pharmaceutical companies and biotechnology firms fuel the discovery of innovative therapies and treatment modalities for desmoid tumors fostering market growth. The development of targeted therapies specific to the molecular characteristics of desmoid tumors offers more precise and effective treatment options, contributing to the growth of the market. Growing awareness among healthcare professionals and the general public about desmoid tumors leads to increased early diagnosis and intervention, creating a demand for therapeutic solutions and positively impacting market growth. Collaborations between pharmaceutical companies, research institutions, and advocacy groups enhance research capabilities, accelerate clinical trials, and contribute to the development of new therapeutic options for desmoid tumors. Regulatory incentives and orphan drug designations present opportunities for accelerated development and approval of novel desmoid tumor treatments, attracting investment and fostering innovation. Exploring untapped regions, especially in emerging markets, provides opportunities for market expansion, where increasing healthcare infrastructure and awareness may drive the demand for desmoid tumor treatments. A shift towards patient-centric healthcare models encourages the development of tailored treatment approaches for desmoid tumor patients, addressing individual needs and improving overall treatment outcomes.

Global Desmoid Tumors Market – Restraints

The global desmoid tumors market faces challenges due to a limited number of approved treatment options, creating a gap in comprehensive therapeutic choices for patients. The intricate and heterogeneous nature of desmoid tumors’ biology poses challenges in developing targeted therapies, hindering the development of effective and universally applicable treatments. Limited awareness among healthcare professionals and the general public about desmoid tumors contributes to delayed diagnosis and intervention, impacting the timely initiation of appropriate treatments. The rare occurrence of desmoid tumors results in relatively small patient populations, making it less attractive for pharmaceutical companies to invest in research and development compared to more developed to more prevalent conditions. The high costs associated with the research and development of new desmoid tumor treatments create a financial barrier for pharmaceutical companies, potentially limiting investment in innovative therapies. According to National Center for Biotechnology Information (NCBI), the cost of desmoid tumors is USD 473,697. The absence of standardized treatment protocols for desmoid tumors leads to variability in clinical approaches, creating challenges in establishing consistent and effective therapeutic interventions. Difficulty in recruiting a sufficient number of patients for clinical trials due to the rarity of desmoid tumors can result in prolonged trial durations slowing down the development of new treatments. Safety concerns and potential side effects associated with desmoid tumor treatments may impact patient acceptance and adherence, limiting the widespread adoption of certain therapies.

Global Desmoid Tumors Market – Geographical Insight

The market for desmoid tumors is segmented into the regions of North America, Latin America, Europe, the Middle East, and Africa. North America is the largest market for desmoid tumors due to advanced healthcare infrastructure, high prevalence of the disease, and ongoing research initiatives. Europe plays a crucial role in the desmoid tumors market, with countries like Germany, France, and the UK contributing to the market growth due to well-established healthcare systems and research capabilities. The Asia-Pacific region is witnessing growth in the desmoid tumors market, fueled by a rising prevalence of the disease, increasing healthcare investment, and a focus on improving access to advanced medical treatment.

Global Desmoid Tumors Market – Opportunities

Opportunities arise in the development of biosimilars for desmoid tumor treatments, prompting competition, affordability, and increased accessibility for patients. Establishing patient advocacy and education programs presents opportunities to raise awareness, promote early diagnosis, and empower desmoid tumor patients in their treatment journey. Regulatory incentives for orphan drug designations present opportunities for accelerated development and approval of novel desmoid tumor treatments, attracting investment and fostering innovation. Given the rarity of pediatric desmoid tumors, opportunities exist for research and development specifically targeting this patient population, addressing their unique needs and challenges.

Global Desmoid Tumors Market – Key development

  • On November 29, 2023, SpringWorks rises on FDA Nod for Desmoid Tumor drugs.
  • On November 29, 2023, the FDA approved Ogsives to treat Desmoid Tumors.
  • On November 27, 2023, the FDA approved Nirogacestat for Desmoid Tumors.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert